129 related articles for article (PubMed ID: 23891935)
1. The conformational ensemble of the disordered and aggregation-protective 182-291 region of ataxin-3.
Invernizzi G; Lambrughi M; Regonesi ME; Tortora P; Papaleo E
Biochim Biophys Acta; 2013 Nov; 1830(11):5236-47. PubMed ID: 23891935
[TBL] [Abstract][Full Text] [Related]
2. The role of the central flexible region on the aggregation and conformational properties of human ataxin-3.
Santambrogio C; Frana AM; Natalello A; Papaleo E; Regonesi ME; Doglia SM; Tortora P; Invernizzi G; Grandori R
FEBS J; 2012 Feb; 279(3):451-63. PubMed ID: 22129356
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
[TBL] [Abstract][Full Text] [Related]
4. Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein.
Saunders HM; Gilis D; Rooman M; Dehouck Y; Robertson AL; Bottomley SP
Protein Sci; 2011 Oct; 20(10):1675-81. PubMed ID: 21780213
[TBL] [Abstract][Full Text] [Related]
5. Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome.
Bonanomi M; Mazzucchelli S; D'Urzo A; Nardini M; Konarev PV; Invernizzi G; Svergun DI; Vanoni M; Regonesi ME; Tortora P
Int J Biochem Cell Biol; 2014 Jun; 51():58-64. PubMed ID: 24685680
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the Josephin Domain protein-protein interaction by molecular dynamics.
Deriu MA; Grasso G; Licandro G; Danani A; Gallo D; Tuszynski JA; Morbiducci U
PLoS One; 2014; 9(9):e108677. PubMed ID: 25268243
[TBL] [Abstract][Full Text] [Related]
7. Protein Environment: A Crucial Triggering Factor in Josephin Domain Aggregation: The Role of 2,2,2-Trifluoroethanol.
Visentin C; Navarro S; Grasso G; Regonesi ME; Deriu MA; Tortora P; Ventura S
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042316
[TBL] [Abstract][Full Text] [Related]
8. Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis.
Ricchelli F; Fusi P; Tortora P; Valtorta M; Riva M; Tognon G; Chieregato K; Bolognin S; Zatta P
Int J Biochem Cell Biol; 2007; 39(5):966-77. PubMed ID: 17300980
[TBL] [Abstract][Full Text] [Related]
9. Functional interactions as a survival strategy against abnormal aggregation.
Masino L; Nicastro G; Calder L; Vendruscolo M; Pastore A
FASEB J; 2011 Jan; 25(1):45-54. PubMed ID: 20810784
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.
Haacke A; Broadley SA; Boteva R; Tzvetkov N; Hartl FU; Breuer P
Hum Mol Genet; 2006 Feb; 15(4):555-68. PubMed ID: 16407371
[TBL] [Abstract][Full Text] [Related]
11. Josephin domain-containing proteins from a variety of species are active de-ubiquitination enzymes.
Tzvetkov N; Breuer P
Biol Chem; 2007 Sep; 388(9):973-8. PubMed ID: 17696782
[TBL] [Abstract][Full Text] [Related]
12. Examination of Ataxin-3 (atx-3) Aggregation by Structural Mass Spectrometry Techniques: A Rationale for Expedited Aggregation upon Polyglutamine (polyQ) Expansion.
Scarff CA; Almeida B; Fraga J; Macedo-Ribeiro S; Radford SE; Ashcroft AE
Mol Cell Proteomics; 2015 May; 14(5):1241-53. PubMed ID: 25700012
[TBL] [Abstract][Full Text] [Related]
13. Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: implication in a loss-of-function pathology.
Yang H; Li JJ; Liu S; Zhao J; Jiang YJ; Song AX; Hu HY
Sci Rep; 2014 Sep; 4():6410. PubMed ID: 25231079
[TBL] [Abstract][Full Text] [Related]
14. The Josephin domain determines the morphological and mechanical properties of ataxin-3 fibrils.
Masino L; Nicastro G; De Simone A; Calder L; Molloy J; Pastore A
Biophys J; 2011 Apr; 100(8):2033-42. PubMed ID: 21504740
[TBL] [Abstract][Full Text] [Related]
15. Mode of substrate recognition by the Josephin domain of ataxin-3, which has an endo-type deubiquitinase activity.
Satoh T; Sumiyoshi A; Yagi-Utsumi M; Sakata E; Sasakawa H; Kurimoto E; Yamaguchi Y; Li W; Joazeiro CA; Hirokawa T; Kato K
FEBS Lett; 2014 Nov; 588(23):4422-30. PubMed ID: 25448680
[TBL] [Abstract][Full Text] [Related]
16. How Epigallocatechin-3-gallate and Tetracycline Interact with the Josephin Domain of Ataxin-3 and Alter Its Aggregation Mode.
Bonanomi M; Visentin C; Natalello A; Spinelli M; Vanoni M; Airoldi C; Regonesi ME; Tortora P
Chemistry; 2015 Dec; 21(50):18383-93. PubMed ID: 26538519
[TBL] [Abstract][Full Text] [Related]
17. Novel polyglutamine model uncouples proteotoxicity from aging.
Christie NT; Lee AL; Fay HG; Gray AA; Kikis EA
PLoS One; 2014; 9(5):e96835. PubMed ID: 24817148
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.
Mao Y; Senic-Matuglia F; Di Fiore PP; Polo S; Hodsdon ME; De Camilli P
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12700-5. PubMed ID: 16118278
[TBL] [Abstract][Full Text] [Related]
19. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
Matos CA; de Macedo-Ribeiro S; Carvalho AL
Prog Neurobiol; 2011 Sep; 95(1):26-48. PubMed ID: 21740957
[TBL] [Abstract][Full Text] [Related]
20. A model for small heat shock protein inhibition of polyglutamine aggregation.
Healy EF; Little C; King PJ
Cell Biochem Biophys; 2014 Jun; 69(2):275-81. PubMed ID: 24242192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
